Close

Morgan Stanley Reiterates Overweight Rating on Gilead Sciences (GILD) Ahead of Yescarta and Zuma Data

June 10, 2021 7:52 AM EDT Send to a Friend
Morgan Stanley analyst Matthew Harrison reiterated an Overweight rating and $83.00 price target on Gilead Sciences (NASDAQ: GILD) noting that ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login